Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery

The objective of this study was to identify the factors associated with improved outcome after treatment for stage III nonsmall cell lung cancer (NSCLC).

[1]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[2]  W. Curran,et al.  Concomitant Radio-chemotherapy (CT-RT) versus Sequential CT-RT In Locally Advanced Non-Small-Cell Lung Cancer (NSCLC): A Meta-Analysis Using Individual Patient Data (IPD) From Randomised Clinical Trials (RCTs) , 2007 .

[3]  R. Govindan,et al.  Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Bezjak,et al.  Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. , 2007, The Journal of thoracic and cardiovascular surgery.

[5]  Joe Y. Chang,et al.  Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. , 2007, International journal of radiation oncology, biology, physics.

[6]  Benjamin Movsas,et al.  Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801 , 2007 .

[7]  J. Herndon,et al.  Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Kelly,et al.  Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). , 2006, Clinical lung cancer.

[9]  M. Ohta,et al.  Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  R. Shemin,et al.  Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. , 2006, The Annals of thoracic surgery.

[11]  J. Jett,et al.  Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[12]  R. T. Ten Haken,et al.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.

[13]  Walter J Curran,et al.  Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Daurès,et al.  Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Michael R. Green,et al.  Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309) , 2005 .

[16]  D. Ettinger,et al.  Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? , 2005, Lung cancer.

[17]  P. Jänne,et al.  High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Ling,et al.  Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[19]  M. Suntharalingam,et al.  Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. , 2004, The Annals of thoracic surgery.

[20]  M. Socinski,et al.  Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  B. Jeremic.  Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[23]  R. Livingston,et al.  Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Socinski,et al.  High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. , 2002, International journal of radiation oncology, biology, physics.

[25]  J. Crowley,et al.  Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Socinski,et al.  Dose‐escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma , 2001, Cancer.

[27]  W. Richards,et al.  Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. , 2000, The Annals of thoracic surgery.

[28]  W. Curran,et al.  Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 , 2000 .

[29]  J. Pignon,et al.  Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Choy,et al.  Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Kerin.  Cancer principles and practice of oncology , 1997 .

[32]  D. Sugarbaker,et al.  Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). , 1997, Lung cancer.

[33]  J. Crowley,et al.  Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  V. Rusch.  Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer. , 1994, The Annals of thoracic surgery.

[35]  J. Crowley,et al.  Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer , 1994 .

[36]  C. Coltman.  Southwest oncology group , 1990, Cancer.

[37]  D. Choy,et al.  A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. , 1988, International journal of radiation oncology, biology, physics.

[38]  R. Komaki,et al.  Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. , 1998, International journal of radiation oncology, biology, physics.

[39]  M. Saunders,et al.  The long-term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

[40]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.